Tampa biotech partners with FIU
March 27, 2019 - Oragenics Inc. will collaborate with Florida International University to expand its pipeline of lantibiotics, a novel class of antibiotics. The collaboration will help Tampa-based Oragenics (NYSE American: OGEN) understand how its lantibiotics interact with bacteria, Alan Joslyn, president and CEO, said in a news release.